December 14, 2007 - Industry leaders, along with state and local officials, joined UCLA Chancellor Gene Block today in a dedication ceremony for UCLA's newly opened California NanoSystems Institute (CNSI) building.
Dedication Ceremony Video
The ceremony was preceded by "CNSI - the Driving Force for California Nanotechnology," a conference featuring industry leaders from the technology and biotechnology sectors who discussed how their companies collaborate with faculty at the CNSI to bring nanoscale technologies into the marketplace for the benefit of the people of California. Over 1,200 people attended the day's events.
Conference speakers included Paolo Gargini, director of technology strategy for Intel Corp.; Patrick Soon-Shiong, chief executive officer of Abraxis BioScience Inc.; Ulrich Müller, research director for BASF Chemical Company; Don Kania, president and CEO of FEI Company; and Stan Williams, director of quantum science research for Hewlett-Packard.
Former California Gov. Gray Davis, Anthony Portantino, Assemblymember, 44th Assembly District, CA and David Crane, Gov. Arnold Schwarzenegger's special adviser for jobs and economic growth, joined Chancellor Block and CNSI interim director Leonard H. Rome as featured speakers at the dedication ceremony. Additional speakers included Hewlett-Packard's Williams, who chairs the CNSI Advisory and Oversight Board, and award-winning architect Rafael Vinoly, founder of Rafael Vinoly Architects and designer of the new CNSI building.
The CNSI is one of four California Institutes of Science and Innovation established in 2000 for the purpose of cultivating stronger partnerships between academia and industry to help move early-stage research developments into the commercial research-and-development pipeline for more rapid delivery of public benefits to the marketplace.
With locations at UCLA and the University of California, Santa Barbara, the CNSI is recognized throughout the world as a leading center for research in nanosystems and nanotechnology. The institute fosters interdisciplinary collaboration in nanoscience and nanotechnology; trains the next generation of scientists, educators and technology leaders; and facilitates partnerships with private industry, fueling economic development and contributing to social well-being in California, the U.S. and the world.
UCLA is at the forefront of nanoscience, with outstanding researchers in the physical sciences, life sciences, engineering and medical sciences. At the CNSI, 75 UCLA faculty members and researchers, working with more than 300 graduate students and postdoctoral scholars, are leading the way in nanoscience, atom by atom and molecule by molecule.
The sophisticated new CNSI building provides the critical lab space, state-of-the-art equipment, technical staff and scientific researchers required for high-level research and development.
The institute is developing the biomedical, manufacturing and information technologies necessary to meet the scientific and economic demands of the 21st century, and its research is expected to generate major advances in health care and medical treatment, environmental remediation and protection, renewable energy, nanobiotechnology and biomaterials, nanoelectronics, information technology, and homeland security.
Technologies being developed at the CNSI ? which have the potential to translate to billions of dollars for the California economy ? include:
Please click here to see the UCLA press release.
- Nanoscale biosensors to aid in early cancer detection.
- Nanocomposite reverse-osmosis membranes to address critical water-sustainability needs.
- Safety assessments of nanomaterials to address potential toxicity to humans and the environment.
- Hydrogen and natural gas storage as alternative fuels for cars.
- Carbon dioxide capture to reduce greenhouse gas emissions from power plants and combustion-engine vehicles.
- Molecular computers that are much smaller and potentially more powerful than today's silicon-based computers.
- New strategies for delivering therapeutics to treat a wide variety of diseases, including cancer, heart disease and diabetes.
- Polymer technologies to replace silicon for capturing solar energy and for low-energy light-emission technologies.
- Next-generation energy-storage batteries.